|
Market Closed -
Euronext Bruxelles
19:55:00 20/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 852.80 EUR | -0.63% |
|
-2.91% | +18.97% |
| 11-19 | Argenx SE : Gets a Neutral rating from Deutsche Bank | ZD |
| 11-19 | US FDA approves Regeneron's drug for generalized myasthenia gravis (November 18) | RE |
| Market Cap | 58.56B 53.33B 49.14B 44.7B 83.86B 5,422B 88.14B 598B 238B 2,962B 220B 215B 9,295B | P/E 2026 * |
31.7x | P/E 2027 * | 26.4x |
|---|---|---|---|---|---|
| Enterprise Value | 54.78B 49.9B 45.98B 41.82B 78.46B 5,073B 82.46B 560B 222B 2,771B 206B 201B 8,696B | EV / Sales 2026 * |
8.45x | EV / Sales 2027 * | 6.6x |
| Free-Float |
100% | Yield 2026 * |
0.07% | Yield 2027 * | 0.11% |
| Markets | Quality | ||
|---|---|---|---|
Euronext Bruxelles
| ARGX | Real-time | |
| ARGXb | Real-time | ||
| ARGNF | Delayed | ||
| 1AE | Real-time | ||
| 0QW0 | Delayed | ||
| 1AE | Real-time | ||
| 1AE | Delayed | ||
| 0QW0 | Real-time | ||
| 1AE | Delayed | ||
| 1AE | Delayed | ||
| ARGX | End-of-day quote |
Last Transcript: argenx SE
| 1 day | -0.63% | ||
| 1 week | -2.91% | ||
| Current month | +5.65% | ||
| 1 month | +8.42% | ||
| 3 months | -5.45% | ||
| 6 months | +20.76% | ||
| Current year | +18.97% |
| 1 week | 849.6 | 892.2 | |
| 1 month | 771.2 | 896 | |
| Current year | 568.4 | 925 | |
| 1 year | 568.4 | 925 | |
| 3 years | 271 | 925 | |
| 5 years | 224.1 | 925 | |
| 10 years | 13.25 | 925 |
| Manager | Title | Age | Since |
|---|---|---|---|
Karen Massey
CEO | Chief Executive Officer | 47 | 06/05/2026 |
Karl Gubitz
DFI | Director of Finance/CFO | 56 | 01/06/2021 |
Filip Borgions
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 54 | 06/05/2026 | |
Joseph deBethizy
BRD | Director/Board Member | 76 | 13/05/2015 |
Pamela Klein
BRD | Director/Board Member | 65 | 28/04/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/23/25 A | Sell | Chief Executive Officer | 2,000 | 0.0032% | ||
| 11/23/25 A | Sell | Director | 4,680 | 0.0076% | ||
| 11/23/25 A | Exercice | Director | 4,680 | 0.0076% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.63% | -2.91% | +6.55% | +89.34% | 58.56B | ||
| -2.49% | -3.76% | +53.38% | +62.10% | 63.66B | ||
| -2.37% | -2.22% | +21.77% | +84.58% | 54.19B | ||
| -2.19% | -6.15% | +12.43% | +111.40% | 44.66B | ||
| -1.89% | -7.28% | +9.30% | +18.50% | 40.51B | ||
| -0.93% | -0.47% | +19.34% | +41.83% | 36.27B | ||
| +1.11% | -6.44% | +127.46% | +675.37% | 34.87B | ||
| -0.80% | +0.61% | +76.27% | +61.80% | 32.26B | ||
| -2.17% | +16.65% | -28.89% | +479.93% | 31.01B | ||
| -6.57% | -12.37% | +34.03% | -15.63% | 21.45B | ||
| Average | -1.89% | -2.33% | +33.16% | +160.92% | 42B | |
| Weighted average by Cap. | -1.74% | -2.39% | +31.94% | +146.36% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.48B 5.91B 5.44B 4.95B 9.29B 600B 9.76B 66.23B 26.33B 328B 24.33B 23.82B 1,029B | 7.98B 7.27B 6.7B 6.09B 11.43B 739B 12.01B 81.49B 32.39B 404B 29.93B 29.3B 1,266B |
| Net income | 1.82B 1.66B 1.53B 1.39B 2.61B 168B 2.74B 18.58B 7.39B 92.01B 6.83B 6.68B 289B | 2.14B 1.95B 1.8B 1.64B 3.07B 199B 3.23B 21.91B 8.71B 108B 8.05B 7.88B 340B |
| Net Debt | -3.77B -3.44B -3.17B -2.88B -5.4B -349B -5.68B -38.54B -15.32B -191B -14.16B -13.86B -599B | -5.93B -5.4B -4.98B -4.53B -8.5B -549B -8.93B -60.6B -24.09B -300B -22.26B -21.79B -942B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/11/26 | €852.80 | -0.63% | 83,546 |
| 19/11/26 | €858.20 | -0.14% | 64,870 |
| 18/11/26 | €859.40 | +0.59% | 69,332 |
| 17/11/26 | €854.40 | -2.64% | 111,065 |
| 16/11/26 | €877.60 | -0.09% | 86,832 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- ARGX Stock
Select your edition
All financial news and data tailored to specific country editions

















